Page 5 - Lyn Castellano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The adoption of the FDA-approved Alzheimer's drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.

United statesMichael greiciusLyn castellanoDonna fickPriya singhalReisa sperlingEric wideraNathaniel chinJames burkeAlex scottAnne whiteSuzanne schindlerWashington university in stStanford university centerAmerican geriatrics societyOhio state university